MedPath

Interventions for Enhancing Adherence to Syphilis Treatment and Follow-up: Study Protocol for the Health Information and Monitoring of Sexually Transmitted Infections (SIM) Randomized Controlled Trial

Not Applicable
Conditions
Syphilis
Interventions
Behavioral: follow-up by telephone
Behavioral: follow-up via a game in a smartphone app
Behavioral: conventional follow-up by a health professional
Registration Number
NCT04753125
Lead Sponsor
Hospital Moinhos de Vento
Brief Summary

The SIM study is a single-centre, randomized, controlled trial with a 12-month follow-up period. The aim is to determine which of the 3 methods of follow-up is the most effective in promoting patient treatment compliance. The recruitment of participants will be done by invitation, and tests will be performed in a mobile unit in locations accessible to large populations. The goal is to perform 10,000 quick tests, with results confirmed by venereal disease research laboratory (VDRL) tests. Patients with a confirmed diagnosis according to VDRL test results will be randomized in one of three monitoring arms: follow-up by telephone, follow-up via a game in a smartphone app, or conventional follow-up by a health professional. All analyses will follow the intention-to-treat principle.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
10000
Inclusion Criteria
  • All adults aged 18 years and older with sorologic test positive for syphilis
Read More
Exclusion Criteria
  • Participants who did not return after three contact attempts will be excluded from the study,
  • pregnant women
  • participants who are not able to provide contact information
  • participants who are illiterate
  • participants those who underwent syphilis treatment within the previous three months.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
compliance for blood testfollow-up by telephonecontrolled trial with a 12-month follow-up period. The aim is to determine which of the 3 methods of follow-up is the most effective in promoting patient treatment compliance, follow-up via a game in a smartphone app through an interactive game with stimuli to pass the phase as the treatment was completed and blood tests were performed in 3,6,9 and 12 months.
demographic socio-economic and sexuality questionnaireconventional follow-up by a health professionalQuestionnaire applied to all patients with positive VDRL
compliance treatmentfollow-up by telephonecontrolled trial with a 12-month follow-up period. The aim is to determine which of the 3 methods of follow-up is the most effective in promoting patient treatment compliance for 3, 6. 9 and 12 months
compliance treatmentfollow-up via a game in a smartphone appcontrolled trial with a 12-month follow-up period. The aim is to determine which of the 3 methods of follow-up is the most effective in promoting patient treatment compliance for 3, 6. 9 and 12 months
compliance for blood testconventional follow-up by a health professionalcontrolled trial with a 12-month follow-up period. The aim is to determine which of the 3 methods of follow-up is the most effective in promoting patient treatment compliance, follow-up via a game in a smartphone app through an interactive game with stimuli to pass the phase as the treatment was completed and blood tests were performed in 3,6,9 and 12 months.
demographic socio-economic and sexuality questionnairefollow-up by telephoneQuestionnaire applied to all patients with positive VDRL
compliance treatmentconventional follow-up by a health professionalcontrolled trial with a 12-month follow-up period. The aim is to determine which of the 3 methods of follow-up is the most effective in promoting patient treatment compliance for 3, 6. 9 and 12 months
compliance for blood testfollow-up via a game in a smartphone appcontrolled trial with a 12-month follow-up period. The aim is to determine which of the 3 methods of follow-up is the most effective in promoting patient treatment compliance, follow-up via a game in a smartphone app through an interactive game with stimuli to pass the phase as the treatment was completed and blood tests were performed in 3,6,9 and 12 months.
demographic socio-economic and sexuality questionnairefollow-up via a game in a smartphone appQuestionnaire applied to all patients with positive VDRL
Primary Outcome Measures
NameTimeMethod
complince of treatmentut to 12 months (July 2023)

3 doses of penicillin g benzathine 3,000,000 UI. The injections are given in the gluteal region once a week from the first dose.

complince of examsup to 12 months (July 2023)

Performing the VDRL blood test that should be done at 3, 6, 9 and 12 months after treatment with penicillin.

Secondary Outcome Measures
NameTimeMethod
identify behavioral risk factors for non-adherence to treatmentupt to 12 months (July 2023)

Identification of risk factors for non-adherence to treatment that will be carried out using a questionnaire applied to study participants with social, racial, sexual, economic and demographic issues.

© Copyright 2025. All Rights Reserved by MedPath